SEARCH RESULTS

FRANCE AT MEDLAB 2019 February 4 to 7, 2019 at DWTC

Rejula ARUN - 03-févr.-2019 11:46:21
• 11 French companies to be gathered on the French pavilion • Major innovations to be exhibited in hematology, biochemistry, pharmacology, toxicology, cytology and pharmacogenetics. United Arab Emirates  2019 : 11 French companies will be taking part in the region’s largest laboratory trade show, in Dubai, from February 4-7, 2019. Showcased across 180 m², the French in vitro diagnostics industry (IVD) will unveil its latest innovative ideas, which are the strategic pillars of the sector’s development. Health innovation goes well beyond medical innovation, particularly because the fields involved, and in particular the in vitro diagnostics industry, are becoming more numerous, diversified and interdependent. The IVD industry forms an essential part of the healthcare system. Over the past several decades, in vitro diagnostics (IVD) manufacturers have been able to gain the efficiency they needed, by investing ever more in scientific and technological innovation. Thanks to a particularly dynamic market, the in vitro diagnostics industry continues to invest massively in R&D and in its own industrial facilities. The major innovations of the companies exhibiting at the French Pavilion are as many breakthroughs in hematology, biochemistry, pharmacology, toxicology, cytology and pharmacogenetics. The laboratory industry in Europe ranks France as the second largest market behind Germany. France is a big producer of medicines driven by a dense industrial ecosystem with +271 production facilities and a highly skilled workforce. In 2017, the turnover of the medicine industry reached 54 billion euros in France, almost 50% intended to be exported. The French btob sector of the pharmaceutical industry gathers around 130 000 employees. Stand to watch: LABELIANS will be exhibiting for the 3rd time in the French Pavilion at MEDLAB Dubai. The teams from LABELIANS will present, at their stand, their full range of pre-analytical, sampling transport, molecular biology, liquid handling products, etc... Plus, in a much- awaited reveal, the FMBIO5 Bioleader® armchair for blood sampling. Conceived and designed by LABELIANS, the FMBIO5 bioleader® armchair for blood sampling is wide, robust and long-lasting. Its ergonomic upholstery and non-slip front cushion provide exceptional seating comfort. It can be equipped with a gynecological kit (paper roll holder, clamps, stainless steel stirrups) or a stainless steel tray. Biomnis, the European leader in specialized medical pathology, will be exhibiting at the France Pavilion at MEDLAB Dubai. The laboratory has chosen this leading congress to present its new range of preventive laboratory tests to its correspondents in the Middle East. Since June 2018, Eurofins Biomnis has been offering clinicians and patients a new comprehensive range of preventive laboratory tests to prevent the signs of aging which the body can experience over time: JUVENALIS®. An evaluation of an individual’s metabolic, hormonal, micronutritional or digestive profiles can help prevent, for instance, the occurrence of pathologies or identify the possible causes of distress. For more info, feel free to contact Business France: Malika HACHEMI Project Manager Business France Tel +33 (0)1 40 73 35 70 malika.hachemi@businessfrance.fr Note to Editors Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France. It promotes France’s companies, business image and nationwide attractiveness as an investment location, and also runs the VIE international internship program. Social Media: Account Most common used hashtags Twitter : @BF_MiddleEast #InfoBF #FrenchPavilion #FrenchHealthcare For more info, feel free to contact Business France: Yasmina OUARI Press Officer – Middle East Mobile: +971 (0)52 99 529 97 Mail : yasmina.ouari@businessfrance.fr  

JUVENALIS®, A NEW RANGE OF PREVENTIVE LABORATORY TESTS

Rejula ARUN - 23-janv.-2019 11:43:57
United Arab Emirates: January 23, 2019 - From February 4-7, 2019, Eurofins Biomnis, the European leader in specialized medical pathology, will be exhibiting at the France Pavilion at MEDLAB Dubai. The laboratory has chosen this leading congress to present its new range of preventive laboratory tests to its correspondents in the Middle East. Since June 2018, Eurofins Biomnis has been offering clinicians and patients a new comprehensive range of preventive laboratory tests to prevent the signs of aging which the body can experience over time: JUVENALIS®. An evaluation of an individual’s metabolic, hormonal, micronutritional or digestive profiles can help prevent, for instance, the occurrence of pathologies or identify the possible causes of distress. Exposed to constant onslaught from pollution, stress or unbalanced diet, the body also undergoes age-related physiological changes (hormonal imbalances, drop in immune defenses, metabolic slowdowns) that contribute to senescence processes, whether organic or, more fundamentally, intracellular. Juvenalis® offers a wide range of tests, each addressing a mechanism or dysfunction evaluated as a whole: the performance of an athlete, identification of an individual’s ideal weight, digestive disorders, premature aging, etc., making for an original and relevant syndrome-based approach. The initial assessment (BasicCheck) and 9 supplementary assessments enable more in-depth exploration through syndromic panels, where appropriate: BasicCheck First-line assessment Very exhaustive assessment of the main harmful mechanisms (oxidative stress, deficiencies, imbalances, etc.) AgeCheck Women Nutritional, hormonal and metabolic testing StressCheck Mental health check-up (sleep, anxiety, memory, etc.) AgeCheck Men Hormonal, cardiovascular and prostate testing DigestCheck Digestive health check-up NutriCheck Vitamins, mineral, oligoelement, fatty acid and amino acid testing WeightCheck Biological profile testing for weight optimization DermaCheck Skin health testing OsteoCheck Bone health testing Sportify Metabolism testing for athletes To supplement this, Nutritol™ offers testing for food intolerances. Three levels of analysis are offered, testing up to 270 foods (dairy products, eggs, gluten, etc.) and additives. MEDLAB helps Eurofins Biomnis strengthen its ties with its current customers, meet new prospects (specialized physicians, private or hospital laboratories), and inform prescribers about the latest developments in hyperspecialized medical pathology, particularly innovative tests. From February 4-7 2019, Eurofins Biomnis will be exhibiting at MEDLAB – Dubai – Stand Z1F50. About Eurofins Biomnis The European leader in the field of specialized medical pathology, Eurofins Biomnis conducts over 32,000 analyses per day on a panel of more than 2,500 examinations, including specialized procedures, having all the necessary accreditations in this regard. Founded in 1897 by Marcel Mérieux, Eurofins Biomnis remains the leading player in specialized pathology in France thanks to continuous innovation and technological investment, particularly in the fields of women’s pathology, oncology and personalized medicine, as well as chromosome and molecular genetics. With 120 years of expertise and innovation in medical pathology, Eurofins Biomnis, the European platform of the Clinical Diagnostics division of the Eurofins Group, is now pursuing its international development. Company contact: EUROFINS BIOMNIS Head of press activities Caroline PASCAULT Wellcom Press Relations Agency: biomnis@wellcom.fr 17/19 avenue Tony Garnier - 69007 Lyon – FRANCE Tel.: +334.72.80.10.10 contact-biomnis@eurofins.com www.eurofins-biomnis.com          

FRANCE AT MEDLAB 2019 February 4 to 7, 2019 at DWTC

Rejula ARUN - 17-janv.-2019 07:35:57
• 11 French companies to be gathered on the French pavilion • Major innovations to be exhibited in hematology, biochemistry, pharmacology, toxicology, cytology and pharmacogenetics. United Arab Emirates, January 16th 2019: 11 French companies will be taking part in the region’s largest laboratory trade show, in Dubai, from February 4-7, 2019. Showcased across 180 m², the French in vitro diagnostics industry (IVD) will unveil its latest innovative ideas, which are the strategic pillars of the sector’s development. Health innovation goes well beyond medical innovation, particularly because the fields involved, and in particular the in vitro diagnostics industry, are becoming more numerous, diversified and interdependent. The IVD industry forms an essential part of the healthcare system. Over the past several decades, in vitro diagnostics (IVD) manufacturers have been able to gain the efficiency they needed, by investing ever more in scientific and technological innovation. Thanks to a particularly dynamic market, the in vitro diagnostics industry continues to invest massively in R&D and in its own industrial facilities. The major innovations of the companies exhibiting at the French Pavilion are as many breakthroughs in hematology, biochemistry, pharmacology, toxicology, cytology and pharmacogenetics. The laboratory industry in Europe ranks France as the second largest market behind Germany. France is a big producer of medicines driven by a dense industrial ecosystem with +271 production facilities and a highly skilled workforce. In 2017, the turnover of the medicine industry reached 54 billion euros in France, almost 50% intended to be exported. The French btob sector of the pharmaceutical industry gathers around 130 000 employees. ARKAB - www.arkab.eu ArkAb develops, manufactures and markets monoclonal human/mouse chimeric antibodies IgG IgA IgM IgE. The products are used for research in health and for in vitro diagnostics immunoassays. ArkAb offers catalog products and also custom made development services of chimeric mAbs. AVALUN SAS - www.avalun.com As a young innovative company, we focus all our energy on developing our next-generation LabPad® POC testing device and its associated Tsmart® range of microcuvettes. Our multidisciplinary team consists of 20 dedicated individuals providing their unique expertise and sharing passion for innovation. BIOLABO SAS - www.biolabo.fr BIOLABO Group offers Analyzers & Reagents with very long shelf life for Biochemistry, Coagulation and Specific Proteins. We are among the very few manufacturers in the world who control the production of both reagents and analyzers for Biochemistry, thanks to the acquisition of BPC in 2016. BIOSYNEX - www.biosynex.com BIOSYNEX is specialized in IVD products. Our R&D is answering to new needs in medical innovative fields: - Rapid Diagnostic Tests (HIV tests...) - Amplix: Molecul Biology qPCR - CellsCheck: 1st instrument for Malaria detection - Serology & Parasitology EUROFINS BIOMNIS - www.biomnis.com European leader in the sector of specialized medical pathology, Eurofins Biomnis was founded in 1897 by Marcel Mérieux and carries out over 32,000 analyses per day from a range of over 2,500 available tests, including specialized tests for which the company has the appropriate authorizations. FAMECO MEDICAL INSTRUMENTS - www.fameco.eu Since 2000 Fameco is a well known leader world-wide for high quality refurbishing of laboratory and hospital systems from the major brands. Our services include warranty, hotline, technical training, spare parts and consumables supply. ILSA DIAGNOSTIC - www.ilsa-diagnostic.com Ilsa Diagnostic is a key player in the field of laboratory instrumentation for IVD. In cytology, optimization of cancer screening using our iDC 20 and Cell Expert products line. In Bio-Banks, ulitmate safety, traceability and storing of samples using our patented 3S-Safe Sampling Systems. LABELIANS - www. elvetec.fr LABELIANS (CML-ID group) is a major player in the laboratory world and the leading distributor of disposables, equipment, furniture and services to medical laboratories in France. Its production unit, CEB, has an expertise in manufacturing Medical Devices (MD) and (IVD), PEHD bottles, OEM products. MEDIFF - www.mediff.fr MEDIFF manufactures and distributes in vitro diagnostic tests for medical use in line with ISO9001:2015 and ISO13485:2016 certifications. Through our concept ONE FOR ALL, we offer a complete solution to our customers by grouping their supplies of laboratory equipments and in vitro medical devices. RAL DIAGNOSTICS - www.ral-diagnostics.fr RAL Diagnostics is a manufacturer of stains and instruments for clinical diagnostics. Kits, reagents and instruments are intended mainly for hematology, microbiology and pathology. SFRI MEDICAL DIAGNOSTICS - www.sfri.fr SFRI - Société Française de Réactifs & d’Instruments - adventure began in 1977. After more than 40 years of experience, SFRI manufactures & exports solutions of In Vitro Diagnostic in more than a 100 countries ! We count around 780 hematology, biochemistry & immunology products in our catalog. For more info, feel free to contact Business France: Malika HACHEMI Project Manager Business France Tel +33 (0)1 40 73 35 70 malika. hachemi@businessfrance.fr Note to Editors Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France. It promotes France’s companies, business image and nationwide attractiveness as an investment location, and also runs the VIE international internship program. Social Media: Account Most common used hashtags Twitter @BF_MiddleEast #InfoBF #FrenchPavilion #FrenchHealthcare  

Medical Expertise Federated Under the French Healthcare Brand at Arab Health 2019

Rejula ARUN - 03-janv.-2019 15:59:52
From January 28th to 31st 2019 at Dubai World Trade Centre • International launch of the brand French Healthcare • 110 exhibiting companies on the French pavilion United Arab Emirates;  January 3rd 2019 - 110 French companies will be exhibiting at the largest health show in the Middle East, 30 of them will be in Dubai for the first time. For the 2019 edition of the French pavilion, Business France, the agency supporting the international development of the French economy will launch the French Healthcare brand, an innovative initiative aimed at bringing together French companies, researchers, and healthcare professionals to jointly promote their activities internationally. On display across 1,400 square meters, French expertise will embrace a wide range of fields: from orthopedics to rehabilitation, sterilization, waste treatment, remote medicine solutions, furniture and equipment for hospitals, implantable medical devices, medical measuring instruments. The collective brand French Healthcare has the ambition to build momentum through a collective approach so as to boost the influence of French health expertise and technologies. The players of the French health ecosystem wishing to join this collective approach can join the French Healthcare organization through this link: https://frenchhealthcare.fr/en/join-us/ . In 2017, the French medical devices market posted €28 billion, earned by more than 1,300 companies, of which 92% are SMEs. The industrial sector generates 85,000 jobs in France. Growth in the sector is fueled in large part by export, an area in which turnover is growing by 5% per year. France offers tremendous potential for innovation in the medical devices sector thanks to recognized industrial, scientific and medical expertise. The medical devices sector stands out for its three-pronged growth model: “reasoned innovation / internationalization / external growth”, with exports as the main driver, in light of the obstacles on the domestic market. In this respect, innovation remains of central importance to these companies. It is illustrated by a desire to develop solutions that integrate new functionalities, in particular developed from e-health technologies. With the support of Sanofi, FedEx and regional partners from France such as Bretagne Commerce International, DEV’UP, Lille Eurasanté and Medicalps, the French Pavilion will give center stage to the latest innovations at the 2019 edition of Arab Health. Their technical nature meets the expectations of the very demanding and rapidly-developing local market. Jean-Paul Scheuer, Country Chair & General Manager, Sanofi Gulf commented: “Delivering innovation in healthcare that will truly benefit patients and improve care is one of the main commitments at Sanofi. I believe that partnerships are vital to realizing this, and the Arab Health conference is a great platform to meet likeminded organizations to exchange insights and experiences and explore potential collaborations. We are always pleased to work with partners who share the same values.” Taarek Hinedi, Vice President Operations, FedEx Express Middle East and Northern Africa added: “Driven by emerging economies, longer life expectancy and technological advancements, the Global Healthcare market is set to cross USD 1.85 trillion this year. FedEx is supporting the complex needs of the industry like temperature-control of sensitive samples and products by providing leading solutions in healthcare logistics. FedEx innovations like SenseAware® track the entire journey of vital healthcare products, delivering new levels of visibility, security and control from start to finish. This is a transformative time for FedEx, and we are continuously working to innovate across entire healthcare supply chains.” The most represented sectors on the French Pavilion are: - Hospital equipment and furniture: medical beds, trolleys, wheelchairs, operating lamps, ergonomic chairs, gynecological examination chairs. - Prevention and risk management in hospitals/hospital hygiene: Equipment sterilization and disinfection, air treatment and purification, hospital waste management, ventilation system, effluent decontamination. - Diagnostics: ultrasound diagnostic equipment, sonography equipment, Doppler, endoscopes, radiography units. - Telemedicine solution: patient monitoring, transmission of medical information.   Note to Editors: Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France. It promotes France’s companies, business image and nationwide attractiveness as an investment location, and also runs the VIE international internship program. Social Media: Account Most common used hashtags Twitter : @BF_MiddleEast #FrenchPavilion #FrenchHealthcare #InfoBF For more info, feel free to contact Business France: Miryem Oukas Messidi Head of Communications – Middle East Mobile: +971 (0)55 478 32 15 Mail : miryem.oukasmessidi@businessfrance.fr

“Choose France!” summit focusing on France’s attractiveness to business, Versailles,

Rejula ARUN - 24-janv.-2018 09:00:14
The President of France will be attending the “Choose France!” summit at the Palace of Versailles on Monday January 22, where distinguished guests will include nearly 140 business leaders representing some the world’s biggest businesses in a wide variety of sectors, from the automotive industry to new technologies, agri-food, financial services and healthcare. The “Choose France!” summit is another key stage in the promotion of France’s attractiveness as a business location after several months of far-reaching economic reforms by the French government. The aim of the event is to highlight how France stands up as an attractive business destination, underpinned by the announcement of various investment projects in France and the presence of 140 business leaders, many of whom are on their way to the World Economic Forum in Davos (Switzerland), who will discuss their ambitions in France with the President, Prime Minister and 16 ministers. Five multinational firms will use the summit to announce major investment projects in France. Each of these will serve as a symbolic illustration – due to either their size, the sums being invested, growth or jobs being generated, or their excellence and significance for sectors of the future. A handful of smaller projects will also be announced during the event. As part of a day largely given over to France’s attractiveness to business, the President of France will also pay an early afternoon visit to Toyota’s industrial plant near Valenciennes (north-eastern France), where the Toyota Yaris is made (3.5 million units produced since opening in 2001) and 3,800 people are employed at a site driving employment in the local area. It is also the 25th largest factory in France, turning out 30% of Toyota’s total output in Europe. Following his visit to Valenciennes, the President will travel straight to the Palace of Versailles, where he is scheduled to arrive around 6pm. He will take part in several bilateral meetings, including with Sheryl Sandberg, Chief Operating Officer of Facebook, Sundar Pichai, CEO of Google Inc., Vasant Narasimhan, CEO of Novartis, Bill McDermott, CEO of SAP and John Chambers, formerly Executive Chairman of Cisco. The bilateral meetings will be followed by a dinner, preceded by an introductory speech from the President and a question-answer session with the invited business leaders.   1. “Choose France!” summit agenda and participants 140 business leaders from nearly 30 countries are taking part in the “Choose France!” summit, including: Sundar Pichai (Google), Sheryl Sandberg (Facebook), Dominic Barton (McKinsey), Stuart Gulliver (HSBC), Jesper Brodin (Ikea), Bill McDermott (SAP), Lloyd Blankfein (Goldman Sachs), David Abney (UPS), Guido Barilla (Barilla), Jason Chen (Acer), Alexandre Dayon (Salesforce), Warren East (Rolls Royce Plc), Michael Evans (Alibaba), Jeffrey Harmening (General Mills), Lars Fruergaard Joergensen (Novo Nordisk), Joe Kaeser (Siemens), Martin Lundsdedt (Volvo Group), Antonio Neri (Hewlett Packard), Shunichi Miyanaga (Mitsubishi), James Quincey (Coca Cola Company), Young Sohn (Samsung Electronics), Richard Liu (JD.com) and Jonas Prising (Manpower Group). Various French business leaders will also be in attendance, including Thomas Buberl (Axa), Jean- Laurent Bonnafe (BNP Paribas), Ross McInnes (Safran) and Emmanuel Faber (Danone). There are four parts to the schedule for the afternoon at the Palace of Versailles: • 1.00pm-2.30pm: Arrival of business leaders for lunch with the French Prime Minister • 2.30pm-6.00pm: Bilateral meetings and topic-based workshop sessions held in parallel: o Tony Estanguet - “Paris 2024: sharing optimism!” o Bruno Le Maire - “Economic reform in France” o Cédric Villani - “Artificial intelligence” o Mounir Mahjoubi - “Digitalization of the French economy” o Muriel Penicaud: “Social transformation in France” o John Chambers: “Innovation and start up ecosystem” • 6.00pm: Arrival of the President of France and bilateral meetings • 8.00pm: Dinner, preceded by an introductory speech from the President of France KEY FIGURES FOR THE “CHOOSE FRANCE!” SUMMIT: • More than 30 countries represented (approx. 50% from Europe, 25% from the United States, 25% from Africa, the Middle East and Asia). • A dozen job-creating investment projects. • The President and Prime Minister of France joined by 16 ministers: Jean-Yves Le Drian (Europe and Foreign Affairs), Bruno Le Maire (Economy and Finance), Muriel Penicaud (Labour), Agnès Buzyn (Solidarity and Health), Gérald Darmanin (Government Action and Public Accounts), Florence Parly (Armed Forces), Nicole Belloubet (Justice), Françoise Nyssen (Culture), Stéphane Travert (Agriculture and Food), Elisabeth Borne (Transport), Laura Flessel (Sport), Mounir Mahjoubi (Digital Affairs), Brune Poirson (Ecological and Inclusive Transition), Delphine Geny-Stephann (Economy and Finance), Nathalie Loiseau (European Affairs) and Benjamin Griveaux (Government Spokesperson). • Around 300 bilateral meetings scheduled during the afternoon at the Palace of Versailles, between business leaders and: o Members of government. o Institutional participants (French telecoms regulator ARCEP, France’s public investment bank Bpifrance, French state investment fund Caisse des Dépôts et Consignations, Ministry for Europe and Foreign Affairs, French government Treasury Directorate DG Trésor, etc.). o Meetings are also scheduled between French and foreign business leaders.   2. Investment projects in France announced at the “Choose France!” summit The investments announced or confirmed by businesses at the “Choose France!” summit amount to a total of nearly €3.5 billion in investment and nearly 2,200 jobs to be created over five years. 2.1. Five major project announcements Toyota announced a €300 million investment at its French site in Valenciennes (Onnaing, Hauts de France region, north-eastern France) The investment is due to lead to: • 700 new permanent jobs and 100 temporary positions by 2020 (the site currently employs 3,800 people, rising ultimately to more than 4,600 people). • Greater capacity at the site to make 300,000 vehicles a year (up from 240,000 at present). • Production of the fourth generation of the Yaris in 2020 and a new model in 2021. Various components currently sourced in Japan will now be sourced in France. SAP confirmed its commitment to innovation in France, investing an estimated €2 billion or more over the next five years SAP’s investment plans include: • Opening a second European incubator in France to support the growth of more than 50 startups through access to SAP’s technology ecosystem. • Investing in French startup seed capital, particularly in startups tackling climate change and working towards sustainable development, where France is currently leading the way. • Spending €150 million a year on R&D over the next five years. • Acquiring a French startup in the deep learning/machine learning field. Facebook announced more investment and a greater presence in France through: • An extra €10 million investment and a doubling in size of its Facebook AI Research (FAIR) teams to fast-track artificial intelligence in France by 2022. o The Facebook AI Research laboratory will employ a further 60 researchers and engineers along with 40 PhD students by 2022. o A boost for French AI research by funding 10 cutting-edge servers for use by research institutes, and through a fund to collect open data. o Funding for bursaries and PhDs in several universities. • A digital skills training initiative for 65,000 people in France by the end of 2019 o Targeting 50,000 people, currently excluded from the workplace, by the end of 2019 in partnership with France’s National Employment Office (Pôle Emploi). o 15,000 women in France will receive support in 2018 with their entrepreneurship plans, in partnership with Social Builder as part of the #SheMeansBusiness initiative.   Google announced a major investment plan with three components: • Four new Google Hubs, each in a different region of France, focusing on free training in online skills and digital literacy, in partnership with local specialists on the ground. • A new AI basic research hub in France, with a team of researchers, in partnership with the French academic community, working on automatic learning, natural-language processing, and the application of IT in the healthcare, science, art and environment sectors. • A 50% increase in personnel at Google’s Paris headquarters (previously announced in September 2017). Novartis confirmed its ambitions to expand in the French biotech sector, announcing: • The completion of its acquisition of Advanced Accelerator Applications, a French biotech firm specializing in molecular nuclear medicine. • Confirmed funding for investments of €900 million over three years in France in clinical research and trials, and at Novartis’ new headquarters in the Paris suburb of Rueil Malmaison, along with the expansion of its industrial plant in the Basel suburb of Huningue (Grand Est region). 2.2. Other project announcements providing further examples of long-term follow-up investments Manpower: A job-creation project in disadvantaged city areas (1,000 permanent and temporary jobs), combined with training focusing on skills in high demand in the local job market. General Mills: A €17 million expansion of a new ice cream production line at its site in Arras (Hauts de France region) in northern France, creating around fifty jobs. East Balt: A €37 million investment in Plessy-Pâté (Ile de France / Paris region), where its third largest sesame bun production plant for Burger King is based, in a move due to create 65 new jobs. Fresh Del Monte: A new €9 million fresh fruit processing factory (10,000 sq. m.) near Amiens (Hauts de France region) in northern France. Airties: A new innovation center in Paris, initially employing 15 engineers, along with an R&D center in Rennes, in a project due to create 120 jobs over three years in Paris and Bretagne (Brittany). SPC: A €20 million greenfield investment in Saint James (Normandie region) to create a frozen pastry factory for this South Korean company, creating 45 jobs initially, with significant further potential. 2.3. Additional government announcements John Chambers has been appointed as an international French Tech ambassador, in an unpaid role to promote France as a business destination to foreign investment funds, leading digital firms and startups. Further to recent announcements concerning Paris as a financial center, the Prime Minister announced three new measures:   • The introduction on March 1, 2018 of international commercial divisions within the Paris Commercial Court and Paris Court of Appeal, which will now be available to hear cases involving contracts entered into in English, with translation provision for proceedings, hearings and judgements. • Greater provision of international classes in primary and secondary school in Ile de France (Paris region), with an aim of ensuring 1,000 places in the region for the beginning of the 2018-19 school year. • Temporary dispensation for expatriates from enrolling in old-age insurance.

Business France sets the stage for robust French participation at Arab Health 2017

YASMINA OUARI - 02-janv.-2017 09:27:00
United Arab Emirates, January 2, 2017– France’s global expertise in healthcare is set to take the centre stage at the Arab Health 2017 as 130 companies from the country, covering a number of key areas of the sector, put on a strong display at the Middle East’s largest healthcare exhibition in Dubai from January 30 to February 2, 2017. Building on the success of the country’s previous participation in the exhibition, France has a bigger presence this year with a quarter of the companies from the country attending the event for the first time. Significantly, the France pavilion, organized by Business France, will host for the first time three major hospitals – Paris Saint Joseph Hospital, Saint Grégoire Private Hospital in Rennes & American Hospital in Paris – which are specialized in disciplines that meet the needs of the Gulf region.  Other participants include manufacturers of high-end hospital furniture and equipment as well as companies with cutting-edge knowledge in decontamination and waste management. The massive French pavilion will be spread across two halls totaling 1,330 square meters of exhibition space.  The French healthcare system has long enjoyed the reputation of being one of the best in the world, and its healthcare industry is supported by a number of innovative companies, with 94% of them in the small and medium enterprises sector. France’s offering covers crucial areas such as  diagnostic imaging, disposable devices, implants, prostheses and ortheses. Innovative devices are being used in promising sectors like surgery to treat pathologies linked to ageing and aesthetic surgery. France has been winning the healthcare market share, consolidating its ranking as the 7th major healthcare supplier thanks to the positive image of its products and its strong reputation in research and development.  Marc Cagnard, Middle East Director at Business France, stated: “France is known for its world class healthcare system, and has played a leading role as a pioneer in healthcare industry. Highlighting the importance of France as a major contributor to the medical industry, pharmaceutical giants such as Sanofi, Bayer AG and AbbVie have chosen to make the country their home. The France pavilion at the Arab Health exhibition this year features a much larger number of companies, reflecting our keen desire to contribute to the development of the healthcare system in the region.” Taking into account sanitary issues faced by hospitals, majority of the French companies attending Arab Health 2017 are involved in the fight against nosocomial, contagious and parasitic diseases. Their areas of specialization include decontamination, sterilization, ventilation, air treatment, oxygen generation, equipment disinfection and waste management. The three hospitals represented at the exhibition will showcase their expertise in the latest research technology, multidisciplinary care and high-quality treatment techniques in areas of significance to the Arab region such as obesity and diabetes treatments, cardiology and vascular surgery, oncology, obstetrics and gynecology, orthopedics, ophthalmology, sports medicine, healthcare assessments, etc. With the help of regional partners such as Centreco-Centrexport, Lille Eurasanté and, for the first time, Bretagne Commerce International and Medicalps (the Grenoble-Isère healthcare technology cluster), each of which will be represented by about ten companies, the France pavilion at Arab Health 2017 will highlight the latest French innovations and technical expertise that meet the demands of the fast-growing local market. Stands To Watch At Arab Health 2017 YSY Medical: the French firm will be presenting its brand new medical device based on pulsed electromagnetic field technology, recognized particularly for pain relief, know as YSY CEMP. They use innovative technologies such as hi-tech sensors and pulsed electromagnetic field, together with unprecedented and exclusive protocols. Its new post-partum indications and hands-free use ensure optimum quality of care. Through sensors applied to the damaged area, pulsed electromagnetic signals accelerate ion exchange in the plasma membrane while restoring the disrupted electrical membrane potential. This field can penetrate deep into tissue and favors microcirculation. YSY CEMP is recommended for the treatment of pain, hematoma, osteoarthritis, sprains and contusions, tendinitis, edema, fractures, knotted trigger points, tears, psychotonic relaxation, etc. More info: www.ysy-medical.fr /  fabrice.nicot@ysy-medical.fr  Trading point: the food supplement manufacturer Trading Point (Elite Pharm group) will be exclusively presenting its new range of food supplements specifically designed to meet the needs of women from pregnancy to breast-feeding. In response to strong market demand, the company has created two unique products that meet the expectations and specific characteristics of these fields of application:  - Pregnancy support: a food supplement that meets the essential nutritional needs of pregnant women. This combination of vitamins and trace elements helps ensure that pregnancy proceeds smoothly and supports fetal development.  - Lactation support: nutritional complex dedicated to breast-feeding women. It supports lactation by improving colostrum and milk’s nutritional quality thanks to its carefully selected plant extracts.   More info:  www.tradingpoint.fr /  commercial@tradingpoint.fr  Saint Romain: the French specialist in easy-to-use designer crockery for the medical sector, will be presenting its new product for 2017, the Easyeat case. Made entirely in France and guaranteed free from bisphenol A, this full set of specially adapted place settings is ideal for the elderly and those with disabilities. It will help users rediscover the pleasure of mealtimes and regain their independence. Standard plates and bowls are available in a range of sizes. They use warm colors to make them easy to locate on the table and their lightness makes them easier to grip and aids independent eating. Unbreakable, they are safe for use in industrial microwaves and dishwashers. Saint Romain operates throughout the world. More info: www.saint-romain-sa.com /  info@saint-romain-sa.com  Solsteo : recognised European leader in the manufacture of top-quality EO sterilisers and Air Purification Systems (scrubbers and catalytic oxidisers). Solsteo is proud to announce new contract to supply the largest EO steriliser in the UAE: It is a 86 cubic meter chamber fitting 32 pallets, and will be delivered in 2017. Equipment robustness and innovative control systems have quickly emerged as a clear competitive advantage for SOLSTEO. Innovation for SOLSTEO implies bringing new technologies in the field of EO sterilization such as PLC-based data recording & EQ-Sim. More info:www.solsteo.com contact@solsteo.com VIMS: for the first time at Arab Health, VIMS is bringing a breakthrough technology, The First Ultra- HD Video Endoscope system to make surgeons’ live easier. The French leader in laparoscopy will be exhibiting an endoscopy column aimed at simplifying the preoperative phase. It is designed to consist of the smallest possible number of devices: a one-piece videoscope and a single-use sterile sheath. This level of rationalization confirms the expertise of video surgery equipment supplier VIMS, which has been at the leading edge of medical imaging technology for nearly 25 years. More info: http://vims-system.com /  e.fabrissin@vims-system.com About Business France Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France. It promotes France’s companies, business image and nationwide attractiveness as an investment location, and also runs the VIE international internship program. Business France has recently launched its first international campaign called: “CREATIVE FRANCE”, in order to promote France’s economic attractiveness, strengthen perceptions towards France image and create positive conditions for French economic development.  For more information: Miryem Oukas Messidi - Regional Communications Manager miryem.oukasmessidi@businessfrance.fr   Ends –   

GCC healthcare experts briefed on innovative technology that helps fight obesity

Rejula ARUN - 22-mai-2016 08:50:31
ReduStim technique uses BioMagnetic field cell activation to stimulate fat reduction United Arab Emirates; 22nd May 2016 - Innovations in medical technology along with healthy eating and regular exercise provide more effective solutions to abdominal obesity and associated risks  Experts in treating obesity organized in Dubai a workshop with the presence of physicians and specialists from the Gulf region. Referring to rising obesity levels among Gulf populations and difficulties in eliminating localized overloads of fat in the human body, the experts also called for improved awareness among doctors, nutritionists and the public on how fast deposits - especially visceral fat - can impair organ function and lead to various lifestyle diseases. “The fat deposits are a curse for the entire population. They obey a complex phenomenon and are steadily increasing in all industrialized countries. The difficulty to overcome localized overloads by a universally applicable method is related to a multitude of parameters - heredity, hormonal, factors, environmental factors, lifestyle, food and so on,” Dr Philippe Blanchemaison, specialist in Angiology and Vascular Medicine and lecturer at the Faculty of Medicine, University of Paris V, said. Dr Blanchemaison was addressing the 1st Meeting on ‘Abdominal Obesity - the risk factors’ organized by the Cosmosoft Group from France to build awareness on its ReduStim medical device solution, a widely applied innovation in eliminating excess abdominal fat. The meeting was attended by over 100 specialists, including endocrinologists, cardiologists, gynaecologists and urologists from various hospitals in the Gulf region, in addition to general physicians, aesthetic physicians and nutritionists. Research shows that abdominal fat is the worst form of fat deposit in the human body, and particularly visceral fat, which refers to fat located around the organs, is more dangerous compared to subcutaneous fat, the other form of abdominal fat found just beneath the skin. Although the body-mass index (BMI) is a reliable metric of total body fat, it does not show how the fat is distributed within the body. An excessive waist circumference however is often a clear indicator of unusually high levels of abdominal fat. Dr Afra bin Katta from the Dubai Health Authority (DHA) reminded the audience of the menacing levels of obesity in Gulf States, adding that it posed a complex healthcare challenge for the region. “Visceral fat cells release fatty acids to the liver, pancreas, heart and other organs causing organ dysfunction, which in turn leads to insulin resistance higher levels of bad (LDL) cholesterol and cardiovascular diseases. It’s also associated with breast cancer and with infertility in men. ” said Dr Bin Katta. “Over 50% of the population in some Gulf States is obese and a few years ago, a study by Lancet journal found Kuwait and Qatar among the top 10 countries in the world with the highest number of obese people. Obesity places a heavy burden on our healthcare budgets and its associated risks have compounded the problem,” added Dr Bin Katta. Regular exercise and dieting can help significantly reduce abdominal fat. “Nevertheless, food consistency associated with a regular exercise will give visible l Significant results only if it is accompanied by medically safe technology that can further stimulate fat reduction. The ReduStim device uses BioMagnetic field cell activation technique, a safe method to mobilise fat, especially the abdominal resistant kind,” said Dr Blanchemaison. A painless technique employed globally and published in recognized medical journals, ReduStim delivers significant lasting results, has no metabolic constraints and respects the natural biological processes of the human body. “I think Redustim is currently the method with the best benefit /risk ratio with real, linear results, a total absence of risk and constant patient satisfaction because of relaxing sessions,” added Dr Blanchemaison. “The Cosmosoft BioMagnetic fields employed by ReduStim reduce body mass by stimulating the biological mechanisms of lipolysis. With a frequency of around 50 Hz, they are at the low end of the electromagnetic spectrum and correspond to weak induced currents that are totally harmless for the skin and the body,” said Daniel Greff, founder of Cosmosoft Group. ENDS About Cosmosoft Advanced Solutions The Cosmosoft Advanced Solutions Group was founded by Daniel Greff, a doctor in biochemistry and innovator in medical solutions. The Group includes PhysioMedica, an electronic production unit based in Tunisia ; Cosmosoft, a distribution company based in France ; Cosmoweb, a company responsible for promoting digital technologies ; and more recently REDUSTIM Healthy Lifestyle Devices FZ-LLC, a Freezone distribution company based in Dubai and Advanced Devices Technology, a mainland distribution company based in Abu Dhabi. For more information, please contact: COSMOSOFT ADVANCED SOLUTIONS – France Liana Jarlier-Manea – Business Manager Tel: +33 1 47 15 25 25 – Mail: export@cosmosoft.biz www.redustim.com  REDUSTIM HEALTHY LIFESTYLE DEVICES – UAE Dr Ahmad Kamal Eddine – Senior Product Manager Tel: +97 15 29 20 32 72 – Mail: dr.eddine@redustim.com Media contacts: Yousra Lahbabi Mobile: +971 (0)56 470 23 82 – Mail : yousra.lahbabi@businessfrance.fr  
About
Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France. It promotes France’s companies, business image and nationwide attractiveness as an investment location, and also runs the VIE international internship program. Founded on January 1, 2015 through a merger between UBIFRANCE and the Invest in France Agency, Business France has 1,500 personnel, both in France and in 70 countries throughout the world, who work with a network of public- and private-sector partners. For further information, please visit:  www.businessfrance.fr Consulting:  Law and regulation Market benchmarking Projects and requests for proposals Contacts : Market prospection Exhibitions and B to B meetings Technologic partnerships Communication : Press and public relations Professional advertisements Commerc

READ MORE

Facebook
Press area & Media Gallery